News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,435 Results
Type
Article (14052)
Company Profile (283)
Press Release (249100)
Section
Business (79425)
Career Advice (152)
Deals (13212)
Drug Delivery (34)
Drug Development (50377)
Employer Resources (31)
FDA (5698)
Job Trends (5120)
News (144242)
Policy (10022)
Tag
Academia (901)
Alliances (21589)
Alzheimer's disease (783)
Antibody-drug conjugate (ADC) (70)
Approvals (5686)
Artificial intelligence (90)
Bankruptcy (99)
Best Places to Work (4550)
Biotechnology (232)
Breast cancer (123)
Cancer (1040)
Cardiovascular disease (84)
Career advice (132)
CAR-T (86)
Cell therapy (248)
Clinical research (40420)
Collaboration (400)
Compensation (155)
COVID-19 (1019)
C-suite (104)
Cystic fibrosis (72)
Data (1073)
Diabetes (98)
Diagnostics (1245)
Earnings (29084)
Events (47474)
Executive appointments (326)
FDA (6145)
Funding (379)
Gene editing (72)
Gene therapy (187)
GLP-1 (335)
Government (1069)
Healthcare (6560)
Infectious disease (1060)
Inflammatory bowel disease (100)
IPO (7233)
Job creations (859)
Job search strategy (127)
Layoffs (194)
Legal (1381)
Lung cancer (154)
Manufacturing (95)
Medical device (2566)
Medtech (2567)
Mergers & acquisitions (6185)
Metabolic disorders (298)
Neuroscience (1078)
NextGen: Class of 2025 (2013)
Non-profit (851)
Northern California (1243)
Obesity (162)
Opinion (93)
Parkinson's disease (86)
Patents (72)
People (25277)
Phase I (14269)
Phase II (18795)
Phase III (11886)
Pipeline (462)
Postmarket research (852)
Preclinical (5983)
Radiopharmaceuticals (208)
Rare diseases (231)
Real estate (1411)
Regulatory (8380)
Research institute (932)
Series A (75)
Southern California (1115)
Startups (1968)
United States (9847)
Vaccines (177)
Weight loss (94)
Date
Last 7 days (379)
Last 30 days (1561)
Last 365 days (20383)
2025 (1607)
2024 (20553)
2023 (22414)
2022 (26822)
2021 (27806)
2020 (23357)
2019 (16224)
2018 (11739)
2017 (13745)
2016 (11839)
2015 (14350)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (146)
Asia (17040)
Australia (2883)
California (2838)
Canada (895)
China (255)
Colorado (106)
Connecticut (118)
Delaware (65)
Europe (36659)
Florida (320)
Georgia (84)
Illinois (180)
Indiana (69)
Maryland (371)
Massachusetts (2249)
Minnesota (113)
New Jersey (707)
New York (781)
North Carolina (450)
Northern California (1243)
Ohio (91)
Pennsylvania (536)
South America (207)
Southern California (1115)
Texas (316)
Washington State (272)
263,435 Results for "lacerta therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Lacerta Therapeutics Expands Executive Leadership Team
Lacerta Therapeutics announces an expansion in the executive leadership team: Kenneth Warrington, Jr., PhD, co-founder of Lacerta, has joined as the company’s Chief Technology Officer, and Darin Falk, PhD, former Vice President of Gene Therapy Programs at Lacerta, will now serve as the company’s Chief Scientific Officer.
March 1, 2022
·
3 min read
Business
Concept Companies Leads Development Efforts on Second Phase for Lacerta Therapeutics in Alachua’s Progress District
Concept Companies, a national commercial real estate developer specializing in turnkey projects, announces the commencement of the design and construction of a new 11,961-square-foot laboratory facility for Lacerta Therapeutics, Inc., a gene therapy company.
May 27, 2022
·
3 min read
BioMidwest
Lacerta and Prevail, A Wholly Owned Subsidiary of Lilly, Sign Agreement to Develop Novel AAV Capsids for CNS Disorders
Lacerta Therapeutics, a leader in the development of adeno-associated virus technologies for the treatment of central nervous system diseases, announced a new AAV capsid licensing and research collaboration agreement with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company.
August 23, 2022
·
2 min read
BioMidwest
GrowFL Announces Lacerta Therapeutics as an Honoree: 11th Annual Florida Companies to Watch
Lacerta Therapeutics is pleased to be among the top 50 second-stage companies in Florida selected as an 11th Annual GrowFL Florida Companies to Watch honoree, a statewide competition that identifies companies expected to see significant growth over the next several years.
February 16, 2022
·
3 min read
Business
Lacerta Therapeutics Appoints Min Wang, PhD, JD and Marc Wolff to its Board of Directors
Lacerta Therapeutics, Inc. a gene therapy company dedicated to the discovery and development of AAV-based gene therapies, appoints Min Wang, PhD, JD and Marc Wolff to its Board of Directors.
November 24, 2021
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Denali Therapeutics Announces Upcoming Presentations on Hunter Syndrome (MPS II) and TransportVehicle™ Enabled Investigational Therapeutic Tividenofusp Alfa at the 2025 WORLDSymposium™
January 30, 2025
·
4 min read
Press Releases
Tango Therapeutics to Present at the Guggenheim SMID Cap Biotechnology Conference
January 30, 2025
·
1 min read
Press Releases
NeuroEM Therapeutics(R) Accepted into StartUp Health’s Alzheimer’s Moonshot Community(TM)
September 19, 2024
·
4 min read
Press Releases
Elevar Therapeutics Announces the Formation and Members of Scientific Advisory Board
January 27, 2025
·
5 min read
1 of 26,344
Next
